Dishman Carbogen Amcis Ltd

NSE: DCAL · BSE: 540701 · Pharmaceuticals & Biotechnology · 11 announcements

Share price: ₹168.19
Market cap: ₹2,637 Cr
Revenue (annual): ₹2,932 Cr
Net profit (annual): ₹97.45 Cr
P/E (TTM): 163.2×Sector 50.4×
Promoter holding: 59.32%+0.00% QoQ
FII holding: 6.86%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Debt & Borrowing 2

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

25 Sep 2026 19:24 IST BSE

Debt & Borrowing

Dishman Carbogen Amcis Debt & Borrowing: ₹4.17 Cr

Dishman Carbogen Amcis Ltd fixed the record date for interest and partial redemption of its NCDs (ISIN: INE385W07059). The redemption totals ₹4.17 Crore.

Value: ₹4.17 Cr

Read the filing ↗

25 Sep 2026 19:19 IST BSE

Debt & Borrowing

Dishman Carbogen Amcis Debt & Borrowing: ₹1.26 Cr

Dishman Carbogen Amcis Ltd has made the sixth quarterly interest payment of ₹1.26 Crore on its non-convertible debentures as per Regulation 57(1).

Value: ₹1.26 Cr

Read the filing ↗